PMID- 36052537 OWN - NLM STAT- MEDLINE DCOM- 20221118 LR - 20231202 IS - 1473-5571 (Electronic) IS - 0269-9370 (Print) IS - 0269-9370 (Linking) VI - 36 IP - 15 DP - 2022 Dec 1 TI - Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy. PG - 2139-2146 LID - 10.1097/QAD.0000000000003374 [doi] AB - OBJECTIVES: To establish the incidence, risk factors and prognostic effect of anemia in children living with HIV (CLWH). DESIGN: Retrospective nested case-control study of patients 0-18 years in five centers in sub-Saharan Africa, 2004-2014. METHODS: Incident cases of anemia were identified from electronic records and matched with CLWH without anemia. We calculated the incidence density of anemia and used conditional logistic regression to evaluate its association with risk factors, stratified by severity and type of anemia. We used a Cox proportional hazards model to evaluate the impact of anemia on survival. RESULTS: Two thousand, one hundred and thirty-seven children were sampled. The incidence density of anemia was 1 per 6.6 CLWH-years. Anemia was moderate in 31.8% and severe in 17.3% of anemia cases, which had 10-year mortality hazards of 3.4 and 4.5, respectively. Microcytic anemia (36% cases) was associated with 2.3-fold hazard of 10-year mortality, and with malnutrition and CD4 + suppression. Normocytic anemia (50.5% cases) was associated with 2.6-fold hazards of 10-year mortality, and with more severe malnutrition, CD4 + suppression, and WHO stage, but inversely associated with lamivudine and nevirapine therapy. Macrocytic anemia (13.5% cases) was neither associated with higher 10-year mortality nor with severe malnutrition or CD4 + suppression but was associated with WHO stage II/III and negatively associated with lamivudine therapy. CONCLUSION: This large multicountry study of CLWH found a high incidence density of anemia. Higher severity, normocytic and microcytic types of anemia were independently associated with long-term mortality. Laboratory studies are needed to decipher the mechanisms of anemia and how it impacts mortality in CLWH. CI - Copyright (c) 2022 Wolters Kluwer Health, Inc. All rights reserved. FAU - Lubega, Joseph AU - Lubega J AD - Baylor College of Medicine. FAU - Grimes, Amanda AU - Grimes A AD - Baylor College of Medicine. FAU - Airewele, Gladstone AU - Airewele G AD - Baylor College of Medicine. FAU - Bulsara, Shaun AU - Bulsara S AD - Baylor College of Medicine. FAU - Kim, Taylor Olmsted AU - Kim TO AD - Baylor College of Medicine. FAU - Haq, Heather AU - Haq H AD - Baylor College of Medicine. FAU - Peckham-Gregory, Erin AU - Peckham-Gregory E AD - Baylor College of Medicine. FAU - Wanless, Sebastian R AU - Wanless SR AD - Baylor International Pediatric AIDS Initiative, Houston, Texas, USA. FAU - Elyanu, Peter AU - Elyanu P AD - Baylor College of Medicine. FAU - Musoke, Philippa AU - Musoke P AD - Makerere University. FAU - Lumumba, Mwita AU - Lumumba M AD - Baylor International Pediatric AIDS Initiative, Houston, Texas, USA. FAU - Kekitiinwa, Adeodata AU - Kekitiinwa A AD - Baylor International Pediatric AIDS Initiative, Houston, Texas, USA. FAU - Matshaba, Mogomotsi AU - Matshaba M AD - Baylor International Pediatric AIDS Initiative, Houston, Texas, USA. FAU - Despotovic, Jenny AU - Despotovic J AD - Baylor College of Medicine. FAU - Scheurer, Michael AU - Scheurer M AD - Baylor College of Medicine. LA - eng GR - P30 CA125123/CA/NCI NIH HHS/United States GR - U54 CA254569/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20220831 PL - England TA - AIDS JT - AIDS (London, England) JID - 8710219 RN - 2T8Q726O95 (Lamivudine) SB - IM MH - Child MH - Humans MH - *HIV Infections/complications/drug therapy/epidemiology MH - Lamivudine MH - Prognosis MH - Retrospective Studies MH - Case-Control Studies MH - *Anemia/complications/epidemiology MH - Risk Factors MH - *Malnutrition PMC - PMC9671853 MID - NIHMS1832748 COIS- Conflicts of Interest The authors declare no conflict of interest. EDAT- 2022/09/03 06:00 MHDA- 2022/11/19 06:00 PMCR- 2023/12/01 CRDT- 2022/09/02 03:43 PHST- 2022/09/03 06:00 [pubmed] PHST- 2022/11/19 06:00 [medline] PHST- 2022/09/02 03:43 [entrez] PHST- 2023/12/01 00:00 [pmc-release] AID - 00002030-202212010-00007 [pii] AID - 10.1097/QAD.0000000000003374 [doi] PST - ppublish SO - AIDS. 2022 Dec 1;36(15):2139-2146. doi: 10.1097/QAD.0000000000003374. Epub 2022 Aug 31.